Regional authorities bet on biotech

Biosimilars are widely seen as a new engine of Korea’s economic growth. The market for the industry is projected to grow to $14.3 billion by 2015, especially after 2013 when patents for major innovator pharmaceuticals expire, according to the Ministry of Knowledge Economy.

Korea also desires to become a high-tech utopia and thus regional governments are seeking to raise their profile as a hu...